0001104659-22-008949.txt : 20220128
0001104659-22-008949.hdr.sgml : 20220128
20220128151428
ACCESSION NUMBER: 0001104659-22-008949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220128
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCNAB JAMES R
CENTRAL INDEX KEY: 0001190126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 22568226
MAIL ADDRESS:
STREET 1: C/O CURIS, INC
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm221868-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-01-28
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001190126
MCNAB JAMES R
310 BROAD STREET
CHARLESTON
SC
29401
1
0
0
0
Common Stock
2022-01-28
4
J
0
51021
A
51021
I
By JT Pharma
Common Stock
1669
D
Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares.
/S/ James R. McNab
2022-01-28